Cambridge, UK - Plasma fibrinogen levels are associated with the risk of CHD, stroke, other vascular mortality, and nonvascular mortality (mainly cancer) in healthy adults, a new meta-analysis shows ...

The emerging use of immunotherapy as a treatment option in metastatic renal cell carcinoma: Real-world evidence from a single UK tertiary cancer centre.

Evidence has linked fibrinogen to increased amyloid plaque deposition around the brain’s vasculature, a poorly understood condition termed cerebral amyloid angiopathy (CAA). Now, scientists led by ...

Patients with ischemic stroke and obstructive sleep apnea (OSA) have elevated fibrinogen levels, which correlate positively with apnea severity, suggest Wessendorf et al in a paper published in the ...

Utilization and cancer detection by U.S. prostate biopsies (2005-2011). Clinical outcome (CO) and predictive factors (PRE) evaluation of a cohort of castration resistant prostate cancer (CRPC) ...

Fesilty is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Fesilty ™ (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in ...

The severe acute respiratory syndrome coronavirus (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19), has infected over 366 million people worldwide and killed ...

The FDA has approved a new fibrinogen concentrate — fibrinogen, human-chmt (Fesilty, Grifols Therapeutics, LLC) — for the treatment of acute bleeding episodes in pediatric and adult patients with ...

What Is Fesilty, and Why Does It Matter? Fesilty (fibrinogen, human-chmt) is a newly approved treatment for sudden bleeding episodes in both children and adults with a rare condition called congenital ...

Fibryga was found to be noninferior to cryoprecipitate based on the total number of units of allogeneic blood products administered during the first 24 hours after termination of cardiopulmonary ...